Charles River Laboratories
239 hedge funds and large institutions have $2.49B invested in Charles River Laboratories in 2013 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 84 increasing their positions, 94 reducing their positions, and 19 closing their positions.
49% more call options, than puts
Call options by funds: $6.2M | Put options by funds: $4.17M
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
15% more capital invested
Capital invested by funds: $2.17B → $2.49B (+$326M)
4% more funds holding
Funds holding: 230 → 239 (+9)
2.19% more ownership
Funds ownership: 95.43% → 97.62% (+2.2%)
11% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 94
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$30.8M |
| 2 |
JP Morgan Chase
New York
|
+$12.5M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.3M |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$12.1M |
| 5 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
+$8.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
-$42.9M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$34.9M |
| 3 |
FC
Fairpointe Capital
Chicago,
Illinois
|
-$16.6M |
| 4 |
Renaissance Technologies
New York
|
-$12M |
| 5 |
Goldman Sachs
New York
|
-$9.65M |
CRL Hedge Fund Activity: Q4 2013 in Review
239 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2013, worth a combined $2.49B — up 15% from $2.17B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new CRL positions and 19 closed out — a net gain of 9 holders — while 84 added to existing stakes and 94 trimmed.
The largest buyer was OMERS Administration Corp, opening a new position worth an estimated $30.8M. The largest seller was Perkins Investment Management, cutting an estimated $42.9M.
- 239 institutional investors held Charles River Laboratories (CRL) as of Q4 2013, up from 230 in Q3 2013.
- Funds reported $2.49B of Charles River Laboratories stock for Q4 2013, up 15% quarter-over-quarter.
- 28 funds opened new Charles River Laboratories positions in Q4 2013 and 19 closed out, a net change of +9 holders.
- The largest Charles River Laboratories buyer in Q4 2013 was OMERS Administration Corp, an estimated $30.8M added.
- The largest Charles River Laboratories seller in Q4 2013 was Perkins Investment Management, an estimated $42.9M sold.
Based on aggregated 13F filings for Q4 2013.